AVANIR PHARMACEUT-A (NASDAQ:AVNR)
1.81
+0.01 (0.56%)
| AVANIR PHARMACEUT-A (NASDAQ:AVNR) Delayed : |
| Previous Close |
$1.80 |
|
52 Week High |
$4.09 |
|
| Open |
$1.79 |
|
52 Week Low |
$0.23 |
| Day High |
$1.81 |
|
P/E |
N/A |
| Day Low |
$1.77 |
|
EPS |
$-0.26 |
| Volume |
320,917 |
|
|
|
| More AVNR Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on AVNR
-
Nov 10, 2009 09:08 AM
AVANIR Pharma (AVNR) Announces Results from Zenvia Phase III STAR Trial
-
Oct 13, 2009 01:58 PM
AVANIR (AVNR) Higher As Phase III Trial Meets Efficacy Endpoint
-
Oct 9, 2009 10:27 AM
Morning Movers 10/09: SCIL, MBRX, CAGC, AVNR, PSTA, SRZ, ELGX Higher; SPPI, ACOR, LXRX Lower
-
Oct 9, 2009 09:06 AM
Avanair Pharma (AVNR) Announces Phase III Zenvia Results in MS Patients
-
Oct 7, 2009 09:16 AM
AVANIR (AVNR) Receives Patent Coverage On Zenvia Well Into 2025
View All Reports
StreetInsider Reports on AVNR by Category
Comments on recent AVNR articles
Comments on AVNR
No comments are currently available.
on Sep 11, 2009
at 10:55 AM ugh I bought this stock at $18.00..I wonder if I will ever see that again
Article: AVANIR Pharmaceuticals (AVNR) Files $75M Mixed Securities Shelf
on Sep 8, 2009
at 07:38 PM For what now? They just diluted the long term share holder by private placement of 4.5 mil. shares to raise money. What will the $75 do enrich the insiders even more while waiting for FDA approval of their only drug.
Article: AVANIR Pharmaceuticals (AVNR) Files $75M Mixed Securities Shelf
on Aug 27, 2009
at 08:51 AM Avanier stock sale Here we go again diluting the share value of the long term investor to support higher salaries, bonuses and stock options to enrich the insiders.
Article: AVANIR Pharma (AVNR) Raises Gross Proceeds of $10.6M Via Sale of 4.5M Shares